Study of molecular interactions with 13C DNP-NMR.

[1]  S. Meier,et al.  Hyperpolarized amino acids for in vivo assays of transaminase activity. , 2009, Chemistry.

[2]  J. Ardenkjaer-Larsen,et al.  Detection of low-populated reaction intermediates with hyperpolarized NMR. , 2009, Chemical communications.

[3]  Jan Henrik Ardenkjaer-Larsen,et al.  Dynamic Nuclear Polarization of [1-13C]pyruvic acid at 4.6 tesla. , 2009, Journal of magnetic resonance.

[4]  T. G. Barros,et al.  Hydroxamic Acids Designed as Inhibitors of Urease , 2009 .

[5]  W. Jahnke,et al.  Time efficient detection of protein–ligand interactions with the polarization optimized PO-WaterLOGSY NMR experiment , 2009, Journal of biomolecular NMR.

[6]  Harald Schwalbe,et al.  Perspectives on NMR in drug discovery: a technique comes of age , 2008, Nature Reviews Drug Discovery.

[7]  C. Hilty,et al.  Time-resolved dynamic nuclear polarization enhanced NMR spectroscopy. , 2008, Angewandte Chemie.

[8]  Craig R. Malloy,et al.  Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR , 2007, Proceedings of the National Academy of Sciences.

[9]  M. Thaning,et al.  Real-time metabolic imaging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  I D Campbell,et al.  Studies of protein-ligand interactions by NMR. , 2003, Biochemical Society transactions.

[11]  Horst Kessler,et al.  NMR-based screening technologies. , 2003, Drug discovery today.

[12]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Claudio Dalvit,et al.  Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability. , 2003, Journal of the American Chemical Society.

[14]  Thomas Peters,et al.  NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. , 2003, Angewandte Chemie.

[15]  Claudio Dalvit,et al.  NMR screening techniques in drug discovery and drug design , 2002 .

[16]  J. Griffin,et al.  Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. , 2002, Analytical chemistry.

[17]  H. Kessler,et al.  Applications of NMR in drug discovery. , 2001, Current opinion in chemical biology.

[18]  W. Jahnke,et al.  Spin label enhanced NMR screening. , 2001, Journal of the American Chemical Society.

[19]  S. LaPlante,et al.  Transferred 13C T1 Relaxation at Natural Isotopic Abundance: A Practical Method for Determining Site-Specific Changes in Ligand Flexibility upon Binding to a Macromolecule , 2000 .

[20]  Wolfgang Jahnke,et al.  Second-Site NMR Screening with a Spin-Labeled First Ligand , 2000 .

[21]  C. Griesinger,et al.  Transferred Cross-Correlated Relaxation: Application to the Determination of Sugar Pucker in an Aminoacylated tRNA-Mimetic Weakly Bound to EF-Tu , 1999 .

[22]  W. Jahnke,et al.  Transferred Cross-Correlated Relaxation Complements Transferred NOE: Structure of an IL-4R-Derived Peptide Bound to STAT-6 , 1999 .

[23]  B. Krajewska,et al.  The effect of phosphate buffer in the range of pH 5.80–8.07 on jack bean urease activity , 1999 .

[24]  Michael J. Shapiro,et al.  NOE Pumping: A Novel NMR Technique for Identification of Compounds with Binding Affinity to Macromolecules , 1998 .

[25]  Stephen W. Fesik,et al.  One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules , 1997 .

[26]  Mengfen Lin,et al.  Diffusion-Edited NMR−Affinity NMR for Direct Observation of Molecular Interactions , 1997 .

[27]  Z. X. Wang,et al.  An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule , 1995, FEBS letters.

[28]  J. Hamilton-miller,et al.  Role of urease in the formation of infection stones: comparison of ureases from different sources , 1981, Infection and immunity.

[29]  M. Goldman,et al.  Principles of dynamic nuclear polarisation , 1978 .

[30]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[31]  D. Doddrell,et al.  Conformation and segmental motion of native and denatured ribonuclease A in solution. Application of natural-abundance carbon-13 partially relaxed Fourier transform nuclear magnetic resonance. , 1971, Journal of the American Chemical Society.

[32]  Christian Ludwig,et al.  Ligand based NMR methods for drug discovery. , 2009, Frontiers in bioscience.

[33]  Michael J. Shapiro,et al.  NOE Pumping. 2. A High-Throughput Method To Determine Compounds with Binding Affinity to Macromolecules by NMR , 2000 .